Zacks Investment Research
07 Jul 2026, 16:41 UTC · 2h ago
ALC vs. IDXX: Which Stock Is the Better Value Option?
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Zacks Investment Research
07 Jul 2026, 16:41 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
Alcon (ALC) and Idexx Laboratories (IDXX) both hold a Zacks Rank of #2 (Buy), indicating positive earnings estimate revision trends. — A 'Buy' rank based on improving earnings outlooks generally supports positive price action for the affected tickers.
+0.30Alcon (ALC) is positioned as a better value play than Idexx Laboratories, carrying a Value grade of B compared to IDXX's grade of D. — Relative valuation suggests ALC may be more attractive to value-oriented investors, though the impact on broad market risk is negligible.
+0.10Which stocks this story touches
The company has a Zacks Rank of #2 (Buy) and a strong Value grade of B.
Continue reading
6 related stories
Search tags
The company has a Zacks Rank of #2 (Buy), though it possesses a poor Value grade of D.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Zacks Investment Research
1h ago
